Wednesday, March 29, 2017

BRIEF-Brainstorm Cell Therapuetics Q4 loss per share $0.03

* Brainstorm announces financial results for 2016 and provides business update

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)